Neurology News

The FDA has granted approval to Azurity Pharmaceuticals Inc. for its oral adjunctive therapy to treat partial seizures in adolescents and adults aged 16 years and older with epilepsy.

Plasma p-tau217 proved an accurate blood-based biomarker of both tau and amyloid-beta pathological brain alterations for those with Down syndrome and may be used alone or with age as a covariate, per a study published in JAMA Neurology.

Patients with nonalcoholic fatty liver disease had an increased risk for dementia, with stronger risk existing for those with comorbid heart disease or stroke, according to a study published in Neurology.

Influenza-like illness conferred increased odds of 30-day stroke in young patients, but vaccination was associated with lower risk compared with non-vaccination, according to data published in Stroke.

Treatment with ketamine significantly improved seizure occurrence related to refractory status epilepticus in both neonates and children, according to results of a study published in Neurology.

Labcorp Diagnostics announced the launch of the first widely accessible blood test that provides direct evidence of neurodegeneration and neuronal injury.

High-dose erythropoietin failed to lower the risk for death among newborns undergoing therapeutic hypothermia for neonatal hypoxic ischemic encephalopathy, according to study findings published in The New England Journal of Medicine.

For adults with migraine and repeated preventive treatment failures, eptinezumab produced significant reductive effects compared with placebo, along with acceptable safety and tolerability, per a study published in Lancet Neurology.

Patients with posttraumatic refractory intracranial hypertension treated with decompressive craniectomy showed reduced mortality and improved recovery at 24 months compared with standard care, per a study published in JAMA Neurology.

Biopharmaceutical company DiaMedica Therapeutics Inc. announced that the FDA placed a clinical hold on its phase 2/3 ReMEDy2 trial of a synthetic protein therapy for treatment of acute ischemic stroke.